
Iqbal Hossain Chowdhury
Examiner (ID: 2288, Phone: (571)272-8137 , Office: P/1652 )
| Most Active Art Unit | 1656 |
| Art Unit(s) | 1652, 1656 |
| Total Applications | 1465 |
| Issued Applications | 927 |
| Pending Applications | 147 |
| Abandoned Applications | 406 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19890571
[patent_doc_number] => 20250115883
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-10
[patent_title] => RECOMBINANTLY EXPRESSED GLUTAMATE OXIDASE
[patent_app_type] => utility
[patent_app_number] => 18/729704
[patent_app_country] => US
[patent_app_date] => 2023-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27498
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18729704
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/729704 | RECOMBINANTLY EXPRESSED GLUTAMATE OXIDASE | Jan 17, 2023 | Pending |
Array
(
[id] => 19862612
[patent_doc_number] => 20250101398
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-27
[patent_title] => FAST ACTING SNARE-CLEAVING ENZYMES
[patent_app_type] => utility
[patent_app_number] => 18/729703
[patent_app_country] => US
[patent_app_date] => 2023-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12489
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18729703
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/729703 | FAST ACTING SNARE-CLEAVING ENZYMES | Jan 16, 2023 | Pending |
Array
(
[id] => 20824310
[patent_doc_number] => 12677849
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-07-14
[patent_title] => High-purity steviol glycosides
[patent_app_type] => utility
[patent_app_number] => 18/155002
[patent_app_country] => US
[patent_app_date] => 2023-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 148
[patent_figures_cnt] => 164
[patent_no_of_words] => 37908
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 288
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18155002
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/155002 | High-purity steviol glycosides | Jan 15, 2023 | Issued |
Array
(
[id] => 18376256
[patent_doc_number] => 20230151339
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => ENGINEERED ARYL SULFATE-DEPENDENT ENZYMES
[patent_app_type] => utility
[patent_app_number] => 18/096933
[patent_app_country] => US
[patent_app_date] => 2023-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 80578
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18096933
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/096933 | ENGINEERED ARYL SULFATE-DEPENDENT ENZYMES | Jan 12, 2023 | Abandoned |
Array
(
[id] => 18649770
[patent_doc_number] => 20230295591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => STABILIZED CELLULASE VARIANTS
[patent_app_type] => utility
[patent_app_number] => 18/152992
[patent_app_country] => US
[patent_app_date] => 2023-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26026
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18152992
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/152992 | Stabilized cellulase variants | Jan 10, 2023 | Issued |
Array
(
[id] => 18436004
[patent_doc_number] => 20230183298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => CARRIER PROTEIN SUBJECTED TO SITE-DIRECTED MUTATION AND USE THEREOF IN PREPARATION OF VACCINE
[patent_app_type] => utility
[patent_app_number] => 18/150496
[patent_app_country] => US
[patent_app_date] => 2023-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6674
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18150496
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/150496 | Carrier protein subjected to site-directed mutation and use thereof in preparation of vaccine | Jan 4, 2023 | Issued |
Array
(
[id] => 19158095
[patent_doc_number] => 20240150802
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => ENGINEERED BIOCATALYSTS FOR THE SYNTHESIS OF GAMMA-HYDROXY AMINO ACIDS
[patent_app_type] => utility
[patent_app_number] => 18/149941
[patent_app_country] => US
[patent_app_date] => 2023-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9501
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18149941
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/149941 | Engineered biocatalysts for the synthesis of gamma-hydroxy amino acids | Jan 3, 2023 | Issued |
Array
(
[id] => 20834180
[patent_doc_number] => 20260193683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-07-09
[patent_title] => ENZYMES, CELLS, AND METHODS FOR PRODUCING LACTONES
[patent_app_type] => utility
[patent_app_number] => 18/722982
[patent_app_country] => US
[patent_app_date] => 2022-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9547
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18722982
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/722982 | ENZYMES, CELLS, AND METHODS FOR PRODUCING LACTONES | Dec 21, 2022 | Pending |
Array
(
[id] => 19770396
[patent_doc_number] => 20250051822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-13
[patent_title] => METHOD FOR IMPROVED PRODUCTION OF INTRACELLULAR PROTEINS IN BACILLUS
[patent_app_type] => utility
[patent_app_number] => 18/720123
[patent_app_country] => US
[patent_app_date] => 2022-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15887
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18720123
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/720123 | METHOD FOR IMPROVED PRODUCTION OF INTRACELLULAR PROTEINS IN BACILLUS | Dec 18, 2022 | Pending |
Array
(
[id] => 18483625
[patent_doc_number] => 20230210926
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => ACOUSTIC REPORTER GENES FOR NONDESTRUCTIVE IN VIVO IMAGING
[patent_app_type] => utility
[patent_app_number] => 18/066814
[patent_app_country] => US
[patent_app_date] => 2022-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47877
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18066814
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/066814 | ACOUSTIC REPORTER GENES FOR NONDESTRUCTIVE IN VIVO IMAGING | Dec 14, 2022 | Pending |
Array
(
[id] => 19020537
[patent_doc_number] => 20240076708
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-07
[patent_title] => HIGH-PURITY STEVIOL GLYCOSIDES
[patent_app_type] => utility
[patent_app_number] => 18/061861
[patent_app_country] => US
[patent_app_date] => 2022-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32125
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18061861
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/061861 | HIGH-PURITY STEVIOL GLYCOSIDES | Dec 4, 2022 | Pending |
Array
(
[id] => 18325657
[patent_doc_number] => 20230123785
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => CRYPTIC METABOLITES AND METHOD FOR ACTIVATING SILENT BIOSYNTHETIC GENE CLUSTERS IN DIVERSE MICROORGANISMS
[patent_app_type] => utility
[patent_app_number] => 18/072800
[patent_app_country] => US
[patent_app_date] => 2022-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9457
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18072800
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/072800 | CRYPTIC METABOLITES AND METHOD FOR ACTIVATING SILENT BIOSYNTHETIC GENE CLUSTERS IN DIVERSE MICROORGANISMS | Nov 30, 2022 | Pending |
Array
(
[id] => 19120353
[patent_doc_number] => 11964316
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-23
[patent_title] => Method for reducing odor in remediation of pesticide chemical contaminated soil
[patent_app_type] => utility
[patent_app_number] => 18/072710
[patent_app_country] => US
[patent_app_date] => 2022-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4103
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 434
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18072710
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/072710 | Method for reducing odor in remediation of pesticide chemical contaminated soil | Nov 30, 2022 | Issued |
Array
(
[id] => 19884158
[patent_doc_number] => 12269851
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-08
[patent_title] => Polypeptide and method of producing IMP using the same
[patent_app_type] => utility
[patent_app_number] => 18/059581
[patent_app_country] => US
[patent_app_date] => 2022-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13249
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18059581
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/059581 | Polypeptide and method of producing IMP using the same | Nov 28, 2022 | Issued |
Array
(
[id] => 20158394
[patent_doc_number] => 12385006
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-12
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 18/721879
[patent_app_country] => US
[patent_app_date] => 2022-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 0
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18721879
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/721879 | None | Nov 13, 2022 | Issued |
Array
(
[id] => 18391720
[patent_doc_number] => 20230159938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => VLP FOR THE TREATMENT OF A LYSOSOMAL STORAGE DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/053198
[patent_app_country] => US
[patent_app_date] => 2022-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20355
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18053198
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/053198 | VLP FOR THE TREATMENT OF A LYSOSOMAL STORAGE DISEASE | Nov 6, 2022 | Abandoned |
Array
(
[id] => 20700261
[patent_doc_number] => 12622952
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-05-12
[patent_title] => Formulations comprising recombinant acid a-glucosidase
[patent_app_type] => utility
[patent_app_number] => 18/053151
[patent_app_country] => US
[patent_app_date] => 2022-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 53
[patent_no_of_words] => 23101
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18053151
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/053151 | Formulations comprising recombinant acid a-glucosidase | Nov 6, 2022 | Issued |
Array
(
[id] => 18295093
[patent_doc_number] => 20230104779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => ENGINEERED KETOREDUCTASE POLYPEPTIDES
[patent_app_type] => utility
[patent_app_number] => 18/049758
[patent_app_country] => US
[patent_app_date] => 2022-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46182
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18049758
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/049758 | Engineered ketoreductase polypeptides | Oct 25, 2022 | Issued |
Array
(
[id] => 18338862
[patent_doc_number] => 20230130811
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => USES AND METHODS FOR SULFATING A SUBSTRATE WITH A MUTATED ARYLSULFOTRANSFERASE
[patent_app_type] => utility
[patent_app_number] => 17/936598
[patent_app_country] => US
[patent_app_date] => 2022-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34661
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17936598
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/936598 | USES AND METHODS FOR SULFATING A SUBSTRATE WITH A MUTATED ARYLSULFOTRANSFERASE | Sep 28, 2022 | Abandoned |
Array
(
[id] => 18597569
[patent_doc_number] => 20230272365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => ARCHAEAL PYRROLYSYL TRNA SYNTHETASES FOR ORTHOGONAL USE
[patent_app_type] => utility
[patent_app_number] => 17/954097
[patent_app_country] => US
[patent_app_date] => 2022-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12187
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17954097
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/954097 | ARCHAEAL PYRROLYSYL TRNA SYNTHETASES FOR ORTHOGONAL USE | Sep 26, 2022 | Pending |